Abstract

Allopurinol 20 mg/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2019 - Volume 23, Number 5

Page(s): 406

Download in electronic PDF format for $75
  • Allopurinol 20 mg/mL in SyrSpend SF pH4 Page 1

Abstract

A formulation for preparing Allopurinol 20 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • allopurinol
  • formulation
  • hyperuricemia
  • chronic gout
  • gouty arthritis
  • gouty nephropathy
  • recurrent calcium oxalate crystals
  • cancer chemotherapy

Related Categories

  • FORMULATIONS
  • MUSCULOSKELETAL DISORDERS
  • UROLOGY/URINARY TRACT

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2019
Pg. 406
Allopurinol 20 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jul/Aug 2013
Pg. 328
Allopurinol Sodium 4-mg/mL Injection
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 1997
Pg. 128-131
Stability of Allopurinol Suspension Compounded from Tablets
Author(s): Alexander Kenneth S, Davar Nipun, Parker Gordon A
Mar/Apr 2004
Pg. 126-129
Basics of Compounding for the Treatment of Warts
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jan/Feb 2019
Pg. 14-21
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2
Author(s): Williams LaVonn A
Sep/Oct 2020
Pg. 413-419
Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt
Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
Jan/Feb 2025
Pg. 42
Allopurinol 20-mg/mL Oral Suspension
Author(s):
May/Jun 1997
Pg. 174
Allopurinol 20-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jan/Feb 2019
Pg. 53
Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2017
Pg. 233
Ketoconazole 20-mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2016
Pg. 426-434
Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions
Author(s): Polonini Hudson C, Loures Sharlene, de Araujo Edson Peter, Brandão Marcos Antônio F, Ferreira Anderson O
Nov/Dec 2019
Pg. 488
Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 490
Sulfasalazine 100 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 46
Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2022
Pg. 143
Lorazepam 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 508
Sulfadiazine 100 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Sep/Oct 2024
Pg. 408-412
Stability of Allopurinol in Extemporaneously Compounded Oral Suspensions with Oral Mix and Oral Mix SF
Author(s): Friciu Mihaela, Cull Erica, Leclair Grégoire
Jul/Aug 2021
Pg. 327
Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored
Author(s): Allen Loyd V Jr